Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Acta Pharmacologica Sinica|March 31, 2022
Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillationXiao-Qin Liu, Yu-Fei Zhang, Hong-Yan Ding, et al.British Journal of Clinical Pharmacology|September 12, 2017
External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipientsJun-Jun Mao, Zheng Jiao, Hwi-Yeol Yun, et al.Ultrasonics Sonochemistry|November 2, 2023
Piezo-photocatalysis for efficient charge separation to promote CO2 photoreduction in nanoclustersXingwang Zhu, Hangmin Xu, Chuanzhou Bi, et al.British Journal of Clinical Pharmacology|February 19, 2008
Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9Zheng Jiao, Jun-Jie Ding, Jie Shen, et al.European Journal of Clinical Pharmacology|July 19, 2008
Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipientsXiao-Yan Qiu, Zheng Jiao, Ming Zhang, et al.Chinese Journal of Natural Medicines|March 27, 2019
Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysisWei-Wei Qin, Li Wang, Zheng Jiao, et al.Journal of Clinical Pharmacology|September 13, 2022
Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant RecipientsZi-Ran Li, Rui-Dong Li, Wan-Jie Niu, et al.Expert Opinion on Drug Safety|September 28, 2021
Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. dataMing-Ming Yan, Shu-Shan Wu, Yu-Peng Qi, et al.Materials (Basel, Switzerland)|May 27, 2023
Highly Efficient and Exceptionally Durable Photooxidation Properties on Co3O4/g-C3N4 SurfacesYelin Dai, Ziyi Feng, Kang Zhong, et al.Basic & Clinical Pharmacology & Toxicology|July 30, 2025
Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti-Xa Assays and UHPLC-MS/MS in Chinese Patients With Atrial FibrillationXiao-Qin Liu, Yi Gu, Yu-Fei Zhang, et al.Pageof 9